These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3492863)

  • 1. Positive and negative syndromes in schizophrenia as a function of chronicity.
    Kay SR; Fiszbein A; Lindenmayer JP; Opler LA
    Acta Psychiatr Scand; 1986 Nov; 74(5):507-18. PubMed ID: 3492863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The positive-negative dimension in schizophrenia: its validity and significance.
    Kay SR; Opler LA
    Psychiatr Dev; 1987; 5(2):79-103. PubMed ID: 2888108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of positive and negative syndromes in chronic schizophrenia.
    Kay SR; Opler LA; Fiszbein A
    Br J Psychiatry; 1986 Oct; 149():439-48. PubMed ID: 3814927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of the positive-negative distinction in schizophrenia.
    Kay SR
    Schizophr Bull; 1990; 16(4):635-52. PubMed ID: 2077641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The positive-negative distinction in drug-free schizophrenic patients. Stability, response to neuroleptics, and prognostic significance.
    Kay SR; Singh MM
    Arch Gen Psychiatry; 1989 Aug; 46(8):711-8. PubMed ID: 2568824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of neuroleptics on specific syndromes and symptoms in schizophrenics with unfavourable long-term course. A 5-year follow-up study of 50 chronic schizophrenics.
    Beckmann H; Fritze J; Franzek E
    Neuropsychobiology; 1992; 26(1-2):50-8. PubMed ID: 1361971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of positive, negative and general psychopathological symptoms among schizophrenia patients at primary care setting: A comparative study.
    Abbas Q; Ramzan Z; Emad F; Rehman RU
    J Pak Med Assoc; 2019 Mar; 69(3):361-366. PubMed ID: 30890828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The core of negative symptoms in schizophrenia: affect or cognitive deficiency?
    Mundt C; Barnett W; Witt G
    Psychopathology; 1995; 28(1):46-54. PubMed ID: 7871120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopathology of Schizophrenia: initial validation of a 5-factor model.
    Lindenmayer JP; Bernstein-Hyman R; Grochowski S; Bark N
    Psychopathology; 1995; 28(1):22-31. PubMed ID: 7871117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status.
    Chemerinski E; Reichenberg A; Kirkpatrick B; Bowie CR; Harvey PD
    Schizophr Res; 2006 Jul; 85(1-3):12-9. PubMed ID: 16624531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized assessment of psychopathology by relatives of mentally disordered patients. Preliminary results of using the positive and negative syndrome scale to compare schizophrenic and affective disorders.
    Nitsche I; Kallert TW
    Psychopathology; 2007; 40(4):242-53. PubMed ID: 17440287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome predictors in acute schizophrenia. Prospective significance of background and clinical dimensions.
    Kay SR; Lindenmayer JP
    J Nerv Ment Dis; 1987 Mar; 175(3):152-60. PubMed ID: 3819711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual information processing in positive, mixed, and negative schizophrenic syndromes.
    Weiner RU; Opler LA; Kay SR; Merriam AE; Papouchis N
    J Nerv Ment Dis; 1990 Oct; 178(10):616-26. PubMed ID: 2230746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopathological dimensions in schizophrenia.
    Cuesta MJ; Peralta V
    Schizophr Bull; 1995; 21(3):473-82. PubMed ID: 7481577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyramidical model of schizophrenia.
    Kay SR; Sevy S
    Schizophr Bull; 1990; 16(3):537-45. PubMed ID: 2287938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-factor model of schizophrenia. Initial validation.
    Lindenmayer JP; Bernstein-Hyman R; Grochowski S
    J Nerv Ment Dis; 1994 Nov; 182(11):631-8. PubMed ID: 7964671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Syndrome and symptom development in long-term follow-up of schizophrenia].
    Franzek E; Beckmann H
    Nervenarzt; 1991 Sep; 62(9):549-56. PubMed ID: 1956474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.